Date: June 22-24, 2020 Location: Virtual Predicine will present three e-posters focusing on liquid biopsy methylation, urine biomarkers, and cfDNA+cfRNA molecular profiling, at the American Association for Cancer Research Virtual Meeting II, taking place June 22-24, 2020. For the first time, Predicine will present its proprietary methylation cell-free DNA (cfDNA) liquid biopsy technology for...
Date: May 29 – 31, 2020 Location: Virtual In collaboration with Northwestern University and Peking University Cancer Hospital, we are presenting a poster at the American Society of Clinical Oncology Virtual Scientific Program. This study demonstrates that PredicineCARE blood-based ctDNA effectively detected the key mutations in HR+ metastatic breast cancer patients in US and...
Date: March 1-4, 2020 Location: Moscone South Convention Center, San Francisco, CA Attend our presentation or schedule a meeting with us here. Presentation: Blood and Urine-based Liquid Biopsy Solutions for TMB and MRD in Clinical Trials In this talk, we’ll present the development and clinical applications of blood and urine-based liquid biopsy solutions using cfDNA...
Date: February 13 – 15, 2020 Location: Moscone West Building, San Francisco, CA In collaboration with Mayo Clinic, Lee Moffitt Cancer Center, Monash University, and Kintor Pharmaceuticals, we are proud to announce our 3 abstracts in prostate cancer at the American Society of Clinical Oncology – Genitourinary Cancers Symposium. Stop by our poster presentations or...
Date: January 13 – 16, 2020 Location: Hilton Miami Downtown, Miami, FL In collaboration with Merck KGaA, we are proud to present “Simultaneous multi-parametric profiling of cell-free RNA (cfRNA) and cell-free tumor DNA (ctDNA) in advanced-stage colorectal cancer” at the AACR Special Conference on Advances in Liquid Biopsies, on Tuesday, January 14th at 4:00pm, poster...
Predicine is committed to supporting next-generation scientists in biomedical sciences. Through Predicine Translational Research Award at Harvard Medical School’s New England Science Symposium 2020 (NESS), we encourage students and fellows to innovate and explore careers in STEM. Every year students and fellows from around the U.S. and the world converge at the NESS to share their research...
September 27 – October 1, 2019 Barcelona, Spain Poster presentation: Peripheral cytotoxic T cell correlates with tumor mutational burden and is predictive for progression free survival in advanced breast cancer
August 20 – 22, 2019 Washington DC Details: Exhibition booth # 205 Presentation: Reshaping Oncology Drug Development Landscape with ctDNA + ctRNA Liquid Biopsy Solutions | August 20, 2019
May 31-June 4, 2019 Chicago, IL Details: Exhibition booth #19135 Satellite symposium: New Era of Biomarker-driven Clinical Trials and Regulatory Approvals in US and China |June 1, 2019 Poster Presentations: Plasma cell free DNA (cfDNA) based somatic aberrations detected in treatment naïve metastatic hormone sensitive prostate cancer (mHSPC), hormonally ablated mHSPC and metastatic castration resistant...
